One explanation for this discrepancy is that the G500 allele may lead to loss of p16INK4a and p14ARF transcripts initially, followed by loss of exon 1α and exon 1β DNA at a latter stage of tumor development. The gene discussed is CDKN2A; the disease is neoplasm.